Acné – 2002

Accutane (isotretinoin) and psychiatric adverse effects.
Wooltorton E.
CMAJ. 2003 Jan 7;168(1):66. Review.

Testing your diagnostic skills(#65). Case No.1. Drug-induced pigmentation.
Baughman R.
Todays FDA. 2002 Nov;14(11):16, 19.

Demographic features and seasonal variations in patients with acne vulgaris in Saudi Arabia: a hospital-based study.
Al-Ameer AM, Al-Akloby OM.
Int J Dermatol. 2002 Dec;41(12):870-1.

The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women.
Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD.
J Invest Dermatol. 2002 Dec;119(6):1317-22.

Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials.
Fehnel SE, McLeod LD, Brandman J, Arbit DI, McLaughlin-Miley CJ, Coombs JH, Martin AR, Girman CJ.
Qual Life Res. 2002 Dec;11(8):809-16.

In vitro bactericidal effect of low-dose ultraviolet B in patients with acne.
Kalayciyan A, Oguz O, Bahar H, Torun MM, Aydemir EH.
J Eur Acad Dermatol Venereol. 2002 Nov;16(6):642-3.

Acne vulgaris as an immune reconstitution syndrome in a patient with AIDS after initiation of antiretroviral therapy.
Kreuter A, Schlottmann R, Altmeyer P, Brockmeyer NH.
J Eur Acad Dermatol Venereol. 2002 Nov;16(6):638.

Robust evidence is needed in treating acne.
Garner S, Eady A, Avery T.
BMJ. 2002 Dec 14;325(7377):1422.

Benign intracranial hypertension with minocycline therapy.
Chapman-Davies A, Lazarevic A.
Clin Exp Optom. 2000 Sep-Oct;83(5):271-273.

Diet and acne revisited.
Thiboutot DM, Strauss JS.
Arch Dermatol. 2002 Dec;138(12):1591-2.

Acne vulgaris: a disease of Western civilization.
Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J.
Arch Dermatol. 2002 Dec;138(12):1584-90.

The stability of tretinoin in tretinoin gel microsphere 0.1%.
Nyirady J, Lucas C, Yusuf M, Mignone P, Wisniewski S.
Cutis. 2002 Nov;70(5):295-8.

Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
Weiss JW, Shavin J, Davis M.
Clin Ther. 2002 Oct;24(10):1706-17.

Patient notes: acne.
[No authors listed]
Postgrad Med. 2002 Nov;112(5):151-2.

Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method.
Lee JB, Chung WG, Kwahck H, Lee KH.
Dermatol Surg. 2002 Nov;28(11):1017-21; discussion 1021.

Familial Mediterranean fever: attacks during isotretinoin treatment.
Alli N, Toy GG.
J Am Acad Dermatol. 2002 Dec;47(6):967.

Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy.
Ng CH, Tam MM, Celi E, Tate B, Schweitzer I.
Australas J Dermatol. 2002 Nov;43(4):262-8.

Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation.
Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T.
J Dermatol Sci. 2002 Nov;30(2):129-35.

Modelling the remission of individual acne lesions in vitro.
Downie MM, Sanders DA, Kealey T.
Br J Dermatol. 2002 Nov;147(5):869-78.

Selective nonablative treatment of acne scarring with 585 nm flashlamp pulsed dye laser.
Patel N, Clement M.
Dermatol Surg. 2002 Oct;28(10):942-5; discussion 945.

Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris.
Czernielewski J, Poncet M, Mizzi F.
Cutis. 2002 Oct;70(4):243-8.

[ANCA-positive vasculitis of the skin and kidneys associated with acne conglobata].
Manz B, Rytter M, Mittag M, Seidel W, Nenoff P.
Hautarzt. 2002 Nov;53(11):730-4. German.

Pregnancy and pregnancy rates in association with isotretinoin (Accutane).
Brinker A, Trontell A, Beitz J.
J Am Acad Dermatol. 2002 Nov;47(5):798-9.

Health disparities in arthritis and musculoskeletal and skin diseases-the dermatology session: National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, December 15-16, 2000.
Taylor SC, Kelly AP, Dupree NE, Kimball AB, Lawrence RC.
J Am Acad Dermatol. 2002 Nov;47(5):770-3.

Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Gloor M, Wasik B, Becker A, Höffler U.
Dermatology. 2002;205(3):260-4.

Stiff-person syndrome associated with oral isotretinoin treatment.
Chroni E, Sakkis T, Georgiou S, Monastirli A, Pasmatzi E, Paschalis C, Tsambaos D.
Neuromuscul Disord. 2002 Nov;12(9):886-8.

The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne.
Carmina E, Godwin AJ, Stanczyk FZ, Lippman JS, Lobo RA.
J Endocrinol Invest. 2002 Oct;25(9):765-8.

Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.
Falsetti L, Gambera A, Andrico S, Sartori E.
Gynecol Endocrinol. 2002 Aug;16(4):275-84.

[Inverse acne nodes in the anal area. Not only incision–excision].
[No authors listed]
MMW Fortschr Med. 2002 Sep 5;144(35-36):6-8. German.

Prolonged remissions of cystic acne and conglobate acne with 13-cis-retinoic acid Peck GL, Olsen TG, Yoder FW et al.
Cunliffe WJ.
Clin Exp Dermatol. 2002 Sep;27(6):539-40.

Pronounced and early acne in Apert’s syndrome: a case successfully treated with oral isotretinoin.
Campanati A, Marconi B, Penna L, Paolinelli M, Offidani A.
Eur J Dermatol. 2002 Sep-Oct;12(5):496-8.

Excessive oral zinc supplementation.
Salzman MB, Smith EM, Koo C.
J Pediatr Hematol Oncol. 2002 Oct;24(7):582-4.

Oral contraception and the treatment of acne: where are we?
Bélisle S.
J Obstet Gynaecol Can. 2002 Jul;24(7):550-1.

[Hormones–underestimated problem in dermatology. Part I. Diseases connected with excessive androgenisation].
Damasiewicz-Bodzek A, Kos-Kudla B.
Pol Merkur Lekarski. 2002 Jun;12(72):539-45. Review. Polish.

A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face.
Gupta AK, Lynde CW, Kunynetz RA, Amin S, Choi K, Goldstein E.
J Cutan Med Surg. 2003 Jan-Feb;7(1):31-7.

Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.
Mills O Jr, Thornsberry C, Cardin CW, Smiles KA, Leyden JJ.
Acta Derm Venereol. 2002;82(4):260-5.

Acne: effect of hormones on pathogenesis and management.
Shaw JC.
Am J Clin Dermatol. 2002;3(8):571-8. Review.

What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome.
Homburg R.
Hum Reprod. 2002 Oct;17(10):2495-9. Review.

Is accutane really dangerous?
[No authors listed]
Med Lett Drugs Ther. 2002 Sep 16;44(1139):82.

Oral contraceptives hold top position as leading choice for women.
[No authors listed]
Contracept Technol Update. 1997 Nov;18(11):133-6.

A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
Nyirady J, Grossman RM, Nighland M, Berger RS, Jorizzo JL, Kim YH, Martin AG, Pandya AG, Schulz KK, Strauss JS.
J Dermatolog Treat. 2001 Sep;12(3):149-57.

Isotretinoin-induced nail fragility and onycholysis.
Onder M, Oztas MO, Oztas P.
J Dermatolog Treat. 2001 Jun;12(2):115-6.

Overview of treatments for acne.
Oprica C, Emtestam L, Nord CE.
Dermatol Nurs. 2002 Aug;14(4):242-6. Review.

Acne 2002.
Hirsch R, Shalita AR.
Cutis. 2002 Aug;70(2):90.

The interaction between acne vulgaris and the psyche.
Baldwin HE.
Cutis. 2002 Aug;70(2):133-9. Review.

Retinoic acid receptors and topical acne therapy: establishing the link between gene expression and drug efficacy.
Del Rosso JQ.
Cutis. 2002 Aug;70(2):127-9. Review.

Isotretinoin made S.M.A.R.T. and simple.
Lowenstein EJ.
Cutis. 2002 Aug;70(2):115-20. Review.

Acne vulgaris, II: treatment.
Oberemok SS, Shalita AR.
Cutis. 2002 Aug;70(2):111-4. Review.

Acne vulgaris, I: pathogenesis and diagnosis.
Oberemok SS, Shalita AR.
Cutis. 2002 Aug;70(2):101-5. Review.

Vitamin A as an anti-inflammatory agent.
Reifen R.
Proc Nutr Soc. 2002 Aug;61(3):397-400. Review.

Isotretinoin in Denmark — 20 years on.
Wildfang IL, Nielsen NH, Jemec GB, Ibsen HH, Avnstorp C.
J Dermatolog Treat. 2002 Sep;13(3):151-2.

Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P, Boorman GC, Donald AE, Davies HD.
J Dermatolog Treat. 2002 Sep;13(3):111-7.

Seasonal variation in acne vulgaris–myth or reality.
Sardana K, Sharma RC, Sarkar R.
J Dermatol. 2002 Aug;29(8):484-8.

11: Antibiotic resistance.
Collignon PJ.
Med J Aust. 2002 Sep 16;177(6):325-9. Review.

Systemic antibiotic therapy for acne: a review.
Kunynetz R.
Skin Therapy Lett. 2002 May;7(5):3-7. Review.

Clindoxyl gel for the treatment of acne vulgaris.
Tan JK.
Skin Therapy Lett. 2002 May;7(5):1-2.

Dexpanthenol cream significantly improves mucocutaneous side effects associated with isotretinoin therapy.
Romiti R, Romiti N.
Pediatr Dermatol. 2002 Jul-Aug;19(4):368.

Long-term safety of spironolactone in acne: results of an 8-year followup study.
Shaw JC, White LE.
J Cutan Med Surg. 2002 Nov-Dec;6(6):541-5. .

[Salicylic acid as a keratolytic agent].
Béani JC.
Ann Dermatol Venereol. 2002 Jun-Jul;129(6-7):933-5. Review. French.

[Doxycycline].
Bonnetblanc JM.
Ann Dermatol Venereol. 2002 Jun-Jul;129(6-7):874-82. Review. French.

[SAPHO syndrome: case report of an 18-year-old man and review of the literature].
Wolf G, Aigner RM, Schwarz T, Lorbach MP.
Wien Klin Wochenschr. 2002 May 15;114(8-9):341-4. German.

Commentary: A UK primary care perspective on treating acne.
Poyner T, Cunliffe B.
BMJ. 2002 Aug 31;325(7362):475-9.

Selective photothermolysis of the sebaceous glands for acne treatment.
Lloyd JR, Mirkov M.
Lasers Surg Med. 2002;31(2):115-20.

Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling.
Paithankar DY, Ross EV, Saleh BA, Blair MA, Graham BS.
Lasers Surg Med. 2002;31(2):106-14.

Minocycline hypersensitivity syndrome manifesting with rhabdomyolysis.
Rahman Z, Weinberg J, Scheinfeld N.
Int J Dermatol. 2002 Aug;41(8):530-1.

Drug-induced Sweet’s syndrome in acne caused by different tetracyclines: case report and review of the literature.
Khan Durani B, Jappe U.
Br J Dermatol. 2002 Sep;147(3):558-62. Review.

Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Ioannides D, Rigopoulos D, Katsambas A.
Br J Dermatol. 2002 Sep;147(3):523-7.

Acne vulgaris.
Webster GF.
BMJ. 2002 Aug 31;325(7362):475-9. Review.

Potential anti-inflammatory effects of topical retinoids and retinoid analogues.
Wolf JE Jr.
Adv Ther. 2002 May-Jun;19(3):109-18. Review.

Oral contraceptives as anti-androgenic treatment of acne.
Lemay A, Poulin Y.
J Obstet Gynaecol Can. 2002 Jul;24(7):559-67. Review.

Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial.
Leyden J, Shalita A, Hordinsky M, Swinyer L, Stanczyk FZ, Weber ME.
J Am Acad Dermatol. 2002 Sep;47(3):399-409.

A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ, Holland KT, Bojar R, Levy SF.
Clin Ther. 2002 Jul;24(7):1117-33.

Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?
Alcalay J, Landau M, Zucker A.
J Dermatolog Treat. 2001 Mar;12(1):9-12.

Trimethoprim-induced aseptic meningitis in an adolescent male.
Redman RC 4th, Miller JB, Hood M, DeMaio J.
Pediatrics. 2002 Aug;110(2 Pt 1):e26.

A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.
Carmina E, Lobo RA.
Clin Endocrinol (Oxf). 2002 Aug;57(2):231-4.

Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome.
Amer SA, Gopalan V, Li TC, Ledger WL, Cooke ID.
Hum Reprod. 2002 Aug;17(8):2035-42.

[Polycystic ovary. The PCO syndrome].
Goldenstein S, Sillem M.
Med Monatsschr Pharm. 2002 Jul;25(7):233-5. Review. German.

Acne therapy: a methodologic review.
Lehmann HP, Robinson KA, Andrews JS, Holloway V, Goodman SN.
J Am Acad Dermatol. 2002 Aug;47(2):231-40. Review.

Treatment of atrophic facial acne scars with a dual-mode Er:YAG laser.
Tanzi EL, Alster TS.
Dermatol Surg. 2002 Jul;28(7):551-5.

Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.
Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL.
J Immunol. 2002 Aug 1;169(3):1535-41.

A community-based epidemiological study of acne vulgaris in Hong Kong adolescents.
Yeung CK, Teo LH, Xiang LH, Chan HH.
Acta Derm Venereol. 2002;82(2):104-7.

Fifty-six cases of acne treated by auricular needle-embedding.
Hou H, Wu T.
J Tradit Chin Med. 2002 Jun;22(2):115-6.

Nudging acne by topical beta-lipohydroxy acid (LHA), a new comedolytic agent.
Pierard GE, Rougier A.
Eur J Dermatol. 2002 Jul-Aug;12(4):XLVII-XLVIII.

Efficacy and safety of a new salicylic acid derivative as a complement of vitamin A acid in acne treatment.
Rougier A, Richard A.
Eur J Dermatol. 2002 Jul-Aug;12(4):XLIX-L.

Interest of a new salicylic acid derivative in the prevention of acne relapses.
Bréno B, Khammari A, Richard A, Rougier A.
Eur J Dermatol. 2002 Jul-Aug;12(4):LI-LIII.

High protective effect of a broad-spectrum sunscreen against tetracycline phototoxicity.
Duteil I, Queille-Roussel C, Rougier A, Richard A, Ortonne JP.
Eur J Dermatol. 2002 Jul-Aug;12(4):X-XI.

Pustular skin disorders: diagnosis and treatment.
Mengesha YM, Bennett ML.
Am J Clin Dermatol. 2002;3(6):389-400. Review.

Lacrimal function and ocular complications in patients treated with systemic isotretinoin.
Bozkurt B, Irkeç MT, Atakan N, Orhan M, Geyik PO.
Eur J Ophthalmol. 2002 May-Jun;12(3):173-6.

Early diagnosis, presenting complaints, and management of hyperandrogenism in adolescents.
Schroeder B.
Curr Womens Health Rep. 2001 Oct;1(2):124-30. Review.

Toxic effects associated with consumption of zinc.
Igic PG, Lee E, Harper W, Roach KW.
Mayo Clin Proc. 2002 Jul;77(7):713-6.

Sebaceous glands in acne patients express high levels of neutral endopeptidase.
Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M.
Exp Dermatol. 2002 Jun;11(3):241-7.

The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R.
Cutis. 2002 Apr;69(4 Suppl):2-15.

Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
Cunliffe WJ, Danby FW, Dunlap F, Gold MH, Gratton D, Greenspan A.
Eur J Dermatol. 2002 Jul-Aug;12(4):350-4.

A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J.
Cutis. 2002 Feb;69(2 Suppl):4-11.

Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
Draelos ZD, Tanghetti EA; Tazarotene Combination Leads to Efficacious Acne Results (CLEAR) Trial Study Group.
Cutis. 2002 Feb;69(2 Suppl):20-9.

Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J.
Cutis. 2002 Feb;69(2 Suppl):12-9.

Acne variants.
Gebauer K.
Am J Clin Dermatol. 2000 May-Jun;1(3):187-9.

Allergic contact dermatitis from benzoyl peroxide transferred by a loving son.
Hernández-Núñez A, Sánchez-Pérez J, Pascual-López M, Aragüés M, García-Díez A.
Contact Dermatitis. 2002 May;46(5):302.

Hormonal therapies in acne.
Shaw JC.
Expert Opin Pharmacother. 2002 Jul;3(7):865-74. Review.

Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report.
Scheman AJ.
Cutis. 2002 Apr;69(4):287-8.

Yasmin–an oral contraceptive with a new progestin.
[No authors listed]
Med Lett Drugs Ther. 2002 Jun 24;44(1133):55-7.

Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
Leyden JJ.
Cutis. 2002 Jun;69(6):475-80.

What’s your assessment? Neonatal acne.
Bielan B.
Dermatol Nurs. 2000 Jun;12(3):187, 193.

Acne: 1991-2001.
Thiboutot D.
J Am Acad Dermatol. 2002 Jul;47(1):109-17.

Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: an open study.
Kawada A, Aragane Y, Tezuka T.
Dermatology. 2002;204(4):301-2.

Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
Akamatsu H, Tomita T, Horio T.
Dermatology. 2002;204(4):277-80.

A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgaris.
Thiboutot D, Jarratt M, Rich P, Rist T, Rodriguez D, Levy S.
Clin Ther. 2002 May;24(5):773-85.

Skin changes and the face. Catvat/Dubrovnik, Croatia–September 20-23, 2001.
Ljubojevic S, Ramos-e-Silva M.
Clin Dermatol. 2002 May-Jun;20(3):317-20.

Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Warner GT, Plosker GL.
Am J Clin Dermatol. 2002;3(5):349-60. Review.

[« Acne and its subtypes » guideline].
Gollnick H.
Hautarzt. 2002 May;53(5):322-7. German.

Tazarotene (tazorac) for acne.
[No authors listed]
Med Lett Drugs Ther. 2002 Jun 10;44(1132):52-3.

[Cosmetic treatments and acne].
Poli F.
Rev Prat. 2002 Apr 15;52(8):859-62. French.

[Topical treatment of acne].
Auffret N.
Rev Prat. 2002 Apr 15;52(8):854-7. Review. French.

[Acne and hormones].
Faure M.
Rev Prat. 2002 Apr 15;52(8):850-3. Review. French.

[Treatment of acne by isotretinoin (general course)].
Chivot M.
Rev Prat. 2002 Apr 15;52(8):845-9. Review. French.

[General antibiotic therapy in acne].
Dréno B.
Rev Prat. 2002 Apr 15;52(8):841-3. Review. French.

[Induced acne].
Humbert P.
Rev Prat. 2002 Apr 15;52(8):838-40. Review. French.

[Clinical aspects of acne].
Daniel F.
Rev Prat. 2002 Apr 15;52(8):831-7. Review. French.

[Mechanisms and causes of acne].
Beylot C.
Rev Prat. 2002 Apr 15;52(8):828-30. Review. French.

Azelaic acid (20%) cream in the treatment of acne vulgaris.
Shemer A, Weiss G, Amichai B, Kaplan B, Trau H.
J Eur Acad Dermatol Venereol. 2002 Mar;16(2):178-9.

Psychosocial effect of common skin diseases.
Barankin B, DeKoven J.
Can Fam Physician. 2002 Apr;48:712-6. Review.

Psychosocial aspects of common skin diseases.
Gupta MA.
Can Fam Physician. 2002 Apr;48:660-2, 668-70. English, French.

Pseudotumor cerebri secondary to minocycline intake.
Ang ER, Zimmerman JC, Malkin E.
J Am Board Fam Pract. 2002 May-Jun;15(3):229-33.

A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris.
Altman RS, Altman LJ, Altman JS.
Dermatology. 2002;204(3):232-5.

Have oral contraceptives reduced the prevalence of acne? a population-based study of acne vulgaris, tobacco smoking and oral contraceptives.
Jemec GB, Linneberg A, Nielsen NH, Frølund L, Madsen F, Jørgensen T.
Dermatology. 2002;204(3):179-84.

Looking back to the future–acne.
Cunliffe WJ.
Dermatology. 2002;204(3):167-72. Review.

Dermatologic agents during pregnancy and lactation: an update and clinical review.
Hale EK, Pomeranz MK.
Int J Dermatol. 2002 Apr;41(4):197-203. Review.

Skin barrier changes induced by aluminum oxide and sodium chloride microdermabrasion.
Rajan P, Grimes PE.
Dermatol Surg. 2002 May;28(5):390-3.

Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals.
Al-Waiz MM, Al-Sharqi AI.
Dermatol Surg. 2002 May;28(5):383-7.

Effectiveness of oral antibiotics and topical retinoid therapy in the treatment of acne in adolescents.
Ebling AM.
Pediatr Nurs. 2001 Jul-Aug;27(4):410-1, 421.

A case of localized acne following radiation therapy.
Song J, Ha SJ, Kim CW, Kim HO.
Acta Derm Venereol. 2002;82(1):69-70.

Benzoyl peroxide: a history of early research and researchers.
Merker PC.
Int J Dermatol. 2002 Mar;41(3):185-8.

Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging.
Guenther LC.
Skin Therapy Lett. 2002 Mar;7(3):1-4. Review.

A pilot investigation to subjectively measure treatment effect and side-effect profile of non-ablative skin remodeling using a 532 nm, 2 ms pulse-duration laser.
Bernstein EF, Ferreira M, Anderson D.
J Cosmet Laser Ther. 2001 Sep;3(3):137-41.

Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.
Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ.
Br J Dermatol. 2002 May;146(5):840-8.

Nurses in research: the treatment of acne.
Haynes M, Dada J.
Nurs Stand. 2002 Apr 17;16(31):33-6.

[Acne inversa (stage 2)].
Wienert V, Breuninger H, Müller RP.
Hautarzt. 2002 Jan;53(1):18-21. Review. German.

[Cyproterone acetate].
Borelli C.
Hautarzt. 2002 Feb;53(2):149. German.

Summary for patients. An unusual « side effect » of an acne drug.
[No authors listed]
Ann Intern Med. 2002 Apr 16;136(8):I38.

High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study.
Rodondi N, Darioli R, Ramelet AA, Hohl D, Lenain V, Perdrix J, Wietlisbach V, Riesen WF, Walther T, Medinger L, Nicod P, Desvergne B, Mooser V.
Ann Intern Med. 2002 Apr 16;136(8):582-9.

Case 3. Scarring from previous acne vulgaris. Basal cell carcinoma (BCC).
Brown SJ, Taylor AE.
Clin Exp Dermatol. 2002 Jan;27(1):82-3.

Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel.
Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW, Persaud AN, Lebwohl M.
Arch Dermatol. 2002 Apr;138(4):481-9.

[Acne in adult women: data from a national study on the relationship between type of acne and markers of clinical hyperandrogenism].
Vexiau P, Baspeyras M, Chaspoux C, Foin N, Allaert FA, Abramovici Y.
Ann Dermatol Venereol. 2002 Feb;129(2):174-8. French.

[Acne fulminans therapy].
Cordoliani F.
Ann Dermatol Venereol. 2002 Jan;129(1 Pt 1):89-92. Review. French.

Are oral contraceptives (OCPs) with anti-androgenic progestins preferred over other OCPs in patients with acne?
Johnson KH.
J Fam Pract. 2002 Jan;51(1):86.

Healthy skin for women: a review of common conditions and therapies.
Casper KA, Mehta BH.
J Am Pharm Assoc (Wash). 2002 Mar-Apr;42(2):206-15; quiz 215-6. Review.

Microbial ecology of human skin in health and disease.
Fredricks DN.
J Investig Dermatol Symp Proc. 2001 Dec;6(3):167-9. Review.

Androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Behçet’s disease and acne vulgaris: a controlled study.
Durusoy C, Alpsoy E, Elpek O, Karpuzoglu G.
Adv Clin Path. 2002 Apr;6(2):87-93.

Laser therapy and microdermabrasion treat acne scars.
Franz R.
Dermatol Nurs. 2001 Oct;13(5):396.

Acne news.
Franz R.
Dermatol Nurs. 2001 Jun;13(3):232, 236.

Candidiasis of the skin and acne.
Courtenay M, Butler M.
Nurs Times. 2002 Feb 28-Mar 6;98(9):55-6.

Acne news.
Franz R.
Dermatol Nurs. 2001 Feb;13(1):63-4.

[Adolescents and contraception. What should the pediatrician know? (Part 2)].
Alvin P, Neu-Janicki AM, Jacquin P, Salinier C.
Arch Pediatr. 2002 Feb;9(2):187-95. French.

New hormonal therapies treat persistent acne in women.
[No authors listed]
Dermatol Nurs. 2000 Aug;12(4):278-9.

[Severe pruriginous acne in dialysed renal failure. Diagnostic difficulties and efficacy of isotretinoin].
Grange F, Mitschler A, Genestier S, Guillaume JC.
Ann Dermatol Venereol. 2001 Nov;128(11):1215-9. French.

Attitudes of female patients regarding oral contraceptives for treatment of acne.
Tan JK, Vasey K, Fung KY.
J Cutan Med Surg. 2001 Nov-Dec;5(6):471-4.

Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.
Wysowski DK, Swann J, Vega A.
J Am Acad Dermatol. 2002 Apr;46(4):505-9.

[Lupus-like disease due to minocycline].
Marai I, Shoenfeld Y.
Harefuah. 2002 Feb;141(2):151-2, 223, 222. Hebrew.

Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity.
Jappe U, Ingham E, Henwood J, Holland KT.
Br J Dermatol. 2002 Feb;146(2):202-9.

Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer.
Ibbotson SH.
Br J Dermatol. 2002 Feb;146(2):178-88. Review.

Cutaneous elimination of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Geusau A, Tschachler E, Meixner M, Päpke O, Stingl G, McLachlan M.
Br J Dermatol. 2001 Dec;145(6):938-43.

Management of acne.
Lehmann HP, Andrews JS, Robinson KA, Holloway VL, Goodman SN.
Evid Rep Technol Assess (Summ). 2001 Mar;(17):1-3. Review.

3D in-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology.
Friedman PM, Skover GR, Payonk G, Kauvar AN, Geronemus RG.
Dermatol Surg. 2002 Mar;28(3):199-204.

Accutane risk management program strengthened.
[No authors listed]
FDA Consum. 2002 Jan-Feb;36(1):8.

[Feminine acne: dermatologic disease or endocrine disease?].
Vexiau P, Chivot M.
Gynecol Obstet Fertil. 2002 Jan;30(1):11-21. Review. French.

Prevalence of mental health problems in acne patients.
Khan MZ, Naeem A, Mufti KA.
J Ayub Med Coll Abbottabad. 2001 Oct-Dec;13(4):7-8.

Changes of comedonal cytokines and sebum secretion after UV irradiation in acne patients.
Suh DH, Kwon TE, Youn JI.
Eur J Dermatol. 2002 Mar-Apr;12(2):139-44.

Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy.
Piérard-Franchimont C, Goffin V, Arrese JE, Martalo O, Braham C, Slachmuylders P, Piérard GE.
Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):112-9.

Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials.
Brache V, Faundes A, Alvarez F, Cochon L.
Contraception. 2002 Jan;65(1):63-74. Review.

The use of therapeutic moisturizers in various dermatologic disorders.
Bikowski J.
Cutis. 2001 Dec;68(5 Suppl):3-11. Review.

The use of cleansers as therapeutic concomitants in various dermatologic disorders.
Bikowski J.
Cutis. 2001 Dec;68(5 Suppl):12-9. Review.

Adapalene in clinical practice.
Leyden J.
Cutis. 2001 Oct;68(4 Suppl):7-9.

Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients.
Zhu XJ, Tu P, Zhen J, Duan YQ.
Cutis. 2001 Oct;68(4 Suppl):55-9.

Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients.
Jacyk WK, Mpofu P.
Cutis. 2001 Oct;68(4 Suppl):48-54.

Adapalene gel 0.1% is effective and well tolerated in acne patients in a dermatology practice setting.
Baker M, Tuley M, Busdiecker FL, Herndon JH Jr, Slayton RM.
Cutis. 2001 Oct;68(4 Suppl):41-7.

Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
Lucky A, Jorizzo JL, Rodriguez D, Jones TM, Stewart DM, Tschen EH, Kanof NB, Miller BH, Wilson DC, Loven KH.
Cutis. 2001 Oct;68(4 Suppl):34-40.

Polarized light photography and videomicroscopy greatly enhance the capability of estimating the therapeuic response to a topical retinoid (adapalene) in acne vulgaris.
Rizova E, Pagnoni PA, Stoudemayer T, Poncet M, Kligman AM.
Cutis. 2001 Oct;68(4 Suppl):25-33.

Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Egan N, Loesche MC, Baker MM.
Cutis. 2001 Oct;68(4 Suppl):20-4.

Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Thiboutot D, Gold MH, Jarratt MT, Kang S, Kaplan DL, Millikan L, Wolfe J, Loesche C, Baker M.
Cutis. 2001 Oct;68(4 Suppl):10-9.

Neonatal acne and cephalic pustulosis: is malassezia the whole story?
Bergman JN, Eichenfield LF.
Arch Dermatol. 2002 Feb;138(2):255-7.

Exploration of retinoid activity and the role of inflammation in acne: issues affecting future directions for acne therapy.
Zouboulis CC.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:63-7. Review.

Endocrinological evaluation and hormonal therapy for women with difficult acne.
Thiboutot DM.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:57-61. Review.

Current issues in antimicrobial therapy for the treatment of acne.
Leyden JJ.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:51-5. Review.

Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne.
Czernielewski J, Michel S, Bouclier M, Baker M, Hensby JC.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:5-12. Review.

The integral role of topical and oral retinoids in the early treatment of acne.
Shalita A.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:43-9. Review.

Adapalene in the treatment of African patients.
Jacyk WK.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:37-42.

A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
Tu P, Li GQ, Zhu XJ, Zheng J, Wong WZ.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:31-6.

An update of recent clinical trials examining adapalene and acne.
Wolf JE.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:23-9. Review.

Pivotal clinical trials of adapalene in the treatment of acne.
Millikan LE.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:19-22. Review.

New photographic techniques for clinical evaluation of acne.
Rizova E, Kligman A.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:13-8.

Current perspectives on the treatment of acne vulgaris and implications for future directions.
Gollnick H.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:1-4. Review.

An epidemiological study of acne in female adults: results of a survey conducted in France.
Poli F, Dreno B, Verschoore M.
J Eur Acad Dermatol Venereol. 2001 Nov;15(6):541-5.

Acne inversa (alias hidradenitis suppurativa).
Jansen I, Altmeyer P, Piewig G.
J Eur Acad Dermatol Venereol. 2001 Nov;15(6):532-40. Review.

Clindamycin phosphate 1% gel in acne vulgaris.
Rizer RL, Sklar JL, Whiting D, Bucko A, Shavin J, Jarratt M.
Adv Ther. 2001 Nov-Dec;18(6):244-52.

Minocycline effectively reduces acid producted by Propionibacterium granulosum.
Higaki S, Kitagawa T, Morohashi M, Yamagishi T.
J Dermatol. 2002 Jan;29(1):20-2.

[Treatment of acne with consequences — pseudotumor cerebri due to hypervitaminosis A].
Meyer-Heim A, Landau K, Boltshauser E.
Praxis (Bern 1994). 2002 Jan 9;91(1-2):23-6. German.

Type I collagen N-telopeptide variation in adolescents receiving oral isotretinoin for severe acne.
Trifirò G, Norbiato G.
J Pediatr Endocrinol Metab. 2002 Jan;15(1):35-9.

Page for patients. Oral contraceptives.
[No authors listed]
Prev Med. 2002 Feb;34(2):125-6.

The effect of benzoyl peroxide and benzoyl peroxide/erythromycin combination on the antioxidative defence system in papulopustular acne.
Basak PY, Gultekin F, Kilinc I, Delibas N.
Eur J Dermatol. 2002 Jan-Feb;12(1):53-7.

Acne vulgaris in skin of color.
Taylor SC, Cook-Bolden F, Rahman Z, Strachan D.
J Am Acad Dermatol. 2002 Feb;46(2 Suppl Understanding):S98-106. Review.